Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 10/20 | 0.65 |
| ▸ | ERBB2 | P04626 | 10/20 | 0.65 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.58 |
| ▸ | SRC | P12931 | 4/20 | 0.55 |
| ▸ | KDR | P35968 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5664053 | 0.99 | EGFR (0.64) | EGFRERBB2KCNH2SRCKDR | |
| SCHEMBL4037044 | 0.83 | EGFR (0.66) | EGFRERBB2KCNH2SRC | |
| Hydrochloric Acid SCHEMBL4034029 | 0.82 | EGFR (0.70) | EGFRERBB2KCNH2SRCKDR | |
| SCHEMBL4029893 | 0.81 | ERBB2 (0.70) | EGFRERBB2KCNH2SRCKDR | |
| SCHEMBL4039826 | 0.81 | EGFR (0.70) | EGFRERBB2KCNH2SRCKDR | |
| SCHEMBL4036837 | 0.81 | EGFR (0.65) | EGFRERBB2KCNH2SRCKDR | |
| SCHEMBL4029084 | 0.80 | EGFR (0.70) | EGFRERBB2KCNH2SRCKDR | |
| SCHEMBL4032431 | 0.79 | EGFR (0.72) | EGFRERBB2KCNH2SRCKDR | |
| Hydrochloric Acid SCHEMBL4037466 | 0.79 | EGFR (0.78) | EGFRERBB2KCNH2SRCKDR | |
| Hydrochloric Acid SCHEMBL4041008 | 0.79 | EGFR (0.75) | EGFRERBB2KCNH2SRCKDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1444211-B1 | QUINAZOLINE DERIVATIVES AS ANTITUMOR AGENTS | ASTRAZENECA AB (SE) | 2009-01-21 | — | — | EP | disclosed |
| EP-1444211-A2 | QUINAZOLINE DERIVATIVES AS ANTITUMOR AGENTS | AstraZeneca AB (SE) | 2004-08-11 | — | — | EP | disclosed |
| WO-2003040109-A2 | QUINAZOLINE DERIVATIVES AS ANTITUMOR AGENTS | ASTRAZENECA AB (SE) | 2003-05-15 | — | — | WO | disclosed |